Scientists re-engineer immune cells to hunt childhood cancer
NCT ID NCT00085930
Summary
This study tested a new treatment for children with high-risk neuroblastoma, a serious childhood cancer. Researchers modified patients' own immune cells to better recognize and attack cancer cells, hoping these 'supercharged' cells would last longer in the body than previous versions. The trial involved 19 participants and focused primarily on evaluating the safety of this experimental approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.